Victrex’s (VCT) “Buy” Rating Reaffirmed at Liberum Capital

Liberum Capital reissued their buy rating on shares of Victrex (LON:VCT) in a research note issued to investors on Tuesday. The firm currently has a GBX 2,440 ($32.84) price target on the stock.

VCT has been the topic of a number of other research reports. Barclays dropped their price objective on Victrex from GBX 2,350 ($31.63) to GBX 2,270 ($30.55) and set an equal weight rating on the stock in a report on Tuesday, November 28th. Berenberg Bank upgraded Victrex to a buy rating and increased their price objective for the stock from GBX 2,000 ($26.92) to GBX 2,600 ($34.99) in a report on Wednesday, September 6th. Peel Hunt increased their price objective on Victrex from GBX 2,100 ($28.26) to GBX 2,300 ($30.96) and gave the stock an add rating in a report on Tuesday, September 5th. Deutsche Bank reaffirmed a hold rating on shares of Victrex in a research report on Thursday, August 24th. Finally, J P Morgan Chase & Co reaffirmed a neutral rating and set a GBX 2,150 ($28.94) target price on shares of Victrex in a research report on Wednesday, September 27th. Eight investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Victrex currently has an average rating of Hold and an average target price of GBX 2,248.91 ($30.27).

Shares of Victrex (LON:VCT) traded up GBX 122 ($1.64) on Tuesday, hitting GBX 2,513 ($33.82). The stock had a trading volume of 264,300 shares, compared to its average volume of 238,635. Victrex has a one year low of GBX 1,695 ($22.81) and a one year high of GBX 2,607 ($35.09).

WARNING: “Victrex’s (VCT) “Buy” Rating Reaffirmed at Liberum Capital” was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at

About Victrex

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex (LON:VCT)

What are top analysts saying about Victrex plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Victrex plc and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit